CIDARA THERAPEUTICS, INC. Forms 3, 4 and 5: Preferred Stock
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 16 rows, 16 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2026-01-07: Reporting owner RA Capital Healthcare Fund LP | Kolchinsky Peter | Shah Rajeev M. | RA CAPITAL MANAGEMENT, L.P.; Form 4; Security Series A Preferred Stock; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2024-07-19: Reporting owner RA Capital Healthcare Fund LP | Shah Rajeev M. | Kolchinsky Peter | RA CAPITAL MANAGEMENT, L.P.; Form 4; Security Series A Preferred Stock; Transaction C Conversion of derivative security.
- 2024-07-18: Reporting owner RA Capital Healthcare Fund LP | Shah Rajeev M. | Kolchinsky Peter | RA CAPITAL MANAGEMENT, L.P.; Form 4; Security Series A Preferred Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2015-04-20: Reporting owner ELMS STEVE; Form 4; Security Convertible Preferred Stock; Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-01-07 | RA Capital Healthcare Fund LP | Kolchinsky Peter | Shah Rajeev M. | RA CAPITAL MANAGEMENT, L.P. Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | Director, 10% Owner | 4 | Series A Preferred Stock Derivative · Indirect · See footnotes | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −89,956 0 owned after | $15,505.00 | 2026-01-09 | |
| 2024-07-19 | RA Capital Healthcare Fund LP | Shah Rajeev M. | Kolchinsky Peter | RA CAPITAL MANAGEMENT, L.P. Director | Director | Director | Director | 4 | Series A Preferred Stock Derivative · Indirect · See footnotes | C Conversion of derivative security | −10,044 89,956 owned after | no price filed | 2024-07-22 | |
| 2024-07-18 | RA Capital Healthcare Fund LP | Shah Rajeev M. | Kolchinsky Peter | RA CAPITAL MANAGEMENT, L.P. Director | Director | Director | Director | 4 | Series A Preferred Stock Derivative · Indirect · See footnotes | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $1,000.00 | 2024-07-22 | |
| 2015-04-20 | ELMS STEVE Director | 4 | Convertible Preferred Stock Derivative · Indirect · By Aisling Capital II, L.P. | C Conversion of derivative security | −8,928,572 0 owned after | $0.00 | 2015-04-22 | |
| 2015-04-20 | ROCKLAGE SCOTT M | 5AM Co-Investors III, L.P. | DIEKMAN JOHN D | Schwab Andrew J. | 5AM VENTURES III, L.P. Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Convertible Preferred Stock Derivative · Indirect · By Limited Partnership | C Conversion of derivative security | −1,764,195 0 owned after | $0.00 | 2015-04-22 | |
| 2015-04-20 | ROCKLAGE SCOTT M | 5AM Co-Investors III, L.P. | DIEKMAN JOHN D | Schwab Andrew J. | 5AM VENTURES III, L.P. Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 4 | Convertible Preferred Stock Derivative · Indirect · By Limited Partnership | C Conversion of derivative security | −45,467 0 owned after | $0.00 | 2015-04-22 | |
| 2015-04-20 | Heron Patrick J Director | 4 | Convertible Preferred Stock Derivative · Indirect · By limited partnership | C Conversion of derivative security | −865,590 0 owned after | $0.00 | 2015-04-22 | |
| 2015-04-20 | Heron Patrick J Director | 4 | Convertible Preferred Stock Derivative · Indirect · By limited partnership | C Conversion of derivative security | −246,668 0 owned after | $0.00 | 2015-04-22 | |
| 2015-04-20 | Kjellson Nina S Director | 4 | Convertible Preferred Stock Derivative · Indirect · By limited partnership | C Conversion of derivative security | −1,156,813 0 owned after | $0.00 | 2015-04-22 | |
| 2015-04-14 holding as of filing | AISLING CAPITAL PARTNERS, LP | Aisling Capital II LP | AISLING CAPITAL PARTNERS LLC | Seachaid Pharmaceuticals, Inc. | Purcell Dennis J | SCHIFF ANDREW N 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Convertible Preferred Stock Derivative · Indirect · By Aisling Capital II, L.P. | Holding | no price filed | 2015-04-14 | ||
| 2015-04-14 holding as of filing | ELMS STEVE Director | 3 | Convertible Preferred Stock Derivative · Indirect · by Aisling Capital II, L.P. | Holding | no price filed | 2015-04-14 | ||
| 2015-04-14 holding as of filing | ROCKLAGE SCOTT M | 5AM VENTURES III, L.P. | DIEKMAN JOHN D | 5AM Co-Investors III, L.P. | Schwab Andrew J. Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Convertible Preferred Stock Derivative · Indirect · by limited partnership | Holding | no price filed | 2015-04-14 | ||
| 2015-04-14 holding as of filing | ROCKLAGE SCOTT M | 5AM VENTURES III, L.P. | DIEKMAN JOHN D | 5AM Co-Investors III, L.P. | Schwab Andrew J. Director, 10% Owner | 10% Owner | 10% Owner | 10% Owner | 10% Owner | 3 | Convertible Preferred Stock Derivative · Indirect · by limited partnership | Holding | no price filed | 2015-04-14 | ||
| 2015-04-14 holding as of filing | Heron Patrick J Director | 3 | Convertible Preferred Stock Derivative · Indirect · by limited partnership | Holding | no price filed | 2015-04-14 | ||
| 2015-04-14 holding as of filing | Heron Patrick J Director | 3 | Convertible Preferred Stock Derivative · Indirect · by limited partnership | Holding | no price filed | 2015-04-14 | ||
| 2015-04-14 holding as of filing | Kjellson Nina S Director | 3 | Convertible Preferred Stock Derivative · Indirect · By limited partnership | Holding | no price filed | 2015-04-14 |